[1]吴思琪,吕 健,席俊羽,等.冰黄肤乐软膏治疗银屑病的有效性和安全性的Meta分析[J].医学信息,2023,36(11):43-49.[doi:10.3969/j.issn.1006-1959.2023.11.008]
 WU Si-qi,LYU Jian,XI Jun-yu,et al.Meta-analysis of the Efficacy and Safety of Binghuang Fule Ointment in the Treatment of Psoriasis[J].Journal of Medical Information,2023,36(11):43-49.[doi:10.3969/j.issn.1006-1959.2023.11.008]
点击复制

冰黄肤乐软膏治疗银屑病的有效性和安全性的Meta分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年11期
页码:
43-49
栏目:
医学数据科学
出版日期:
2023-06-01

文章信息/Info

Title:
Meta-analysis of the Efficacy and Safety of Binghuang Fule Ointment in the Treatment of Psoriasis
文章编号:
1006-1959(2023)11-0043-07
作者:
吴思琪吕 健席俊羽
(1.中国中医科学院中医临床基础医学研究所,北京 100700;2.中国中医科学院西苑医院,北京 100091)
Author(s):
WU Si-qiLYU JianXI Jun-yuet al.
(1.Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;2.Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,China)
关键词:
银屑病冰黄肤乐软膏有效性安全性
Keywords:
PsoriasisBinghuang Fule ointmentEfficacySafety
分类号:
R275
DOI:
10.3969/j.issn.1006-1959.2023.11.008
文献标志码:
A
摘要:
目的 评价冰黄肤乐软膏治疗银屑病的有效性和安全性。方法 计算机在CNKI、Wan Fang、VIP、CBM、PubMed、Cochrane Library、EMbase以及Web of Sciense 8个数据库系统中搜索冰黄肤乐软膏治疗银屑病的随机对照试验,在合理遴选文献并获得数据后,利用Review Manager 5.4软件进行Meta分析。结果 纳入10项RCTs,共757例受试者,其中试验组394例,对照组363例。Meta分析结果表明:冰黄肤乐软膏联合常规治疗的皮损消退情况优于单用常规治疗[RR=1.68,95%CI(1.38,2.05),P<0.000 01];二者疗效指数有效率[RR=1.77,95%CI(0.90,3.49),P=0.10]、治疗后PASI评分相当[MD=0.09,95%CI(-0.30,0.48),P=0.65];两组不良反应发生率[RR=0.94,95%CI(0.65,1.35),P=0.74]、复发率[RR=0.56,95%CI(0.27,1.16),P=0.12]比较,差异无统计学意义。结论 在常规治疗基础上加用冰黄肤乐软膏可有效减少银屑病患者皮损面积,减轻患者症状体征,但两者疗效指数有效率相当。同时还可减少药物刺激性,不会加重不良反应及复发率。
Abstract:
Objective To apprize the efficacy and safety of Binghuang Fule ointment in the treatment of psoriasis.Methods Randomized controlled trials (RCTs) of Binghuang Fule ointment in the treatment of psoriasis were searched in 8 databases, including CNKI, Wan Fang, VIP, CBM, PubMed, Cochrane Library, EMbase and Web of Sciense. After the literature was reasonably selected and the data were obtained, Meta-analysis was performed using Review Manager 5.4 software.Results A total of 10 RCTs involving 757 subjects were included, including 394 subjects in the experimental group and 363 subjects in the control group. The results of Meta-analysis showed that the skin lesion regression of Binghuang Fule ointment combined with conventional treatment group was better than that of conventional treatment group [RR=1.68, 95%CI(1.38, 2.05), P<0.000 01]. The effective rate of efficacy index [RR=1.77, 95%CI(0.90, 3.49), P=0.10 ] and PASI score after treatment were comparable [MD=0.09, 95%CI(-0.30, 0.48), P=0.65]. There was no significant difference in the incidence of adverse reactions [RR=0.94, 95%CI(0.65, 1.35), P=0.74] and recurrence rate [RR=0.56, 95%CI(0.27, 1.16), P=0.12] between the two groups.Conclusion On the basis of conventional treatment, the use of Binghuang Fule ointment can effectively reduce the skin lesion area of patients with psoriasis and reduce the symptoms and signs, but the effective rate of the two efficacy indexes is equivalent. At the same time, it can also reduce drug irritation and will not aggravate adverse reactions and recurrence rates.

参考文献/References:

[1]郑丹翎.基于网络调查的银屑病患者危险因素比较分析[D].合肥:安徽医科大学,2020.[2]丁晓岚,王婷琳,沈佚葳,等.中国六省市银屑病流行病学调查[J].中国皮肤性病学杂志,2010,24(7):598-601.[3]龚坚,刘巧.中西医结合治疗银屑病思路与方法[J].中华中医药杂志,2021,36(7):4100-4103.[4]袁端锋,倪艳华,石岩.冰黄肤乐凝胶剂的制备及其止痒作用的研究[J].山西医药杂志,2015,44(4):454-457.[5]中华医学会皮肤性病学分会银屑病专业委员会.中国银屑病诊疗指南(2018完整版)[J].中华皮肤科杂志,2019,52(10):667-710.[6]苏蓓蓓,于建斌,张江安,等.冰黄肤乐软膏联合复方甘草酸苷治疗寻常性银屑病疗效观察[J].中国皮肤性病学杂志,2009,23(2):125-126.[7]韩春雷,彭建梅,叶笑好.冰黄肤乐软膏联合氯倍他索霜治疗寻常型银屑病临床观察[J].中国皮肤性病学杂志,2006,20(2):123-125.[8]曾建中,贾叙锋,孙华.冰黄肤乐软膏联合窄谱中波紫外线治疗寻常型银屑病的临床分析[J].中国医院用药评价与分析,2009,9(10):764-765.[9]张浩,冉玉平,眭维耻.冰黄肤乐软膏治疗寻常性银屑病临床疗效观察[J].中华皮肤科杂志,2009,42(8):587.[10]王鹏,高瑾,迪丽努尔,等.冰黄肤乐软膏治疗银屑病疗效观察[J].中国皮肤性病学杂志,2006,20(12):774-775.[11]刘涛,杜宇,陈德宇.补骨脂注射液联合冰黄肤乐软膏治疗寻常型银屑病疗效观察[J].岭南皮肤性病科杂志,2008,15(1):25-26.[12]李海燕.中药制剂治疗寻常型银屑病的临床疗效观察[J].首都医药,2010,17(24):19.[13]曹鸿玮,郑晓红,王瑞,等.冰黄肤乐软膏联合奥深软膏治疗寻常型银屑病临床疗效观察[J].四川中医,2008(11):96-97.[14]代喆,陈晓霞.冰黄肤乐软膏治疗寻常型银屑病32例[J].四川省卫生管理干部学院学报,2008,27(1):31.[15]孙亚丽,陈洪云,梁伟.冰黄肤乐软膏联合丹参注射液治疗寻常型银屑病40例[J].重庆医学,2004,33(8):1195-1202.[16]赵霞.硫黄及其制剂冰黄肤乐软膏的质量控制研究[D].北京:北京中医药大学,2020.[17]王成玉.冰黄肤乐软膏的体外抗菌活性观察[J].山东医药,2010,50(33):18.[18]刘春梅,雷佳,周志宏,等.冰黄肤乐软膏体外抗炎抗菌及皮肤毒性评价研究[J].中国医药科学,2021,11(7):1-4.

相似文献/References:

[1]郑文新,刘 红,汪 伟.银屑病易感基因的生物信息分析[J].医学信息,2018,31(21):1.[doi:10.3969/j.issn.1006-1959.2018.21.001]
 ZHENG Wen-Xin,LIU Hong,WANG Wei.Bioinformatics Analysis of the Susceptible Genes of Psoriasis[J].Journal of Medical Information,2018,31(11):1.[doi:10.3969/j.issn.1006-1959.2018.21.001]
[2]李小智,丁长松,黄辛迪.基于数据挖掘的中医治疗银屑病临床用药规律研究[J].医学信息,2021,34(01):4.[doi:10.3969/j.issn.1006-1959.2021.01.002]
 LI Xiao-zhi,DING Chang-song,HUANG Xin-di.Research on the Law of Clinical Use of Traditional Chinese Medicine for Psoriasis Based on Data Mining[J].Journal of Medical Information,2021,34(11):4.[doi:10.3969/j.issn.1006-1959.2021.01.002]
[3]唐 文,陈爱军.银屑病相关肾脏损害的发病机制[J].医学信息,2021,34(06):36.[doi:10.3969/j.issn.1006-1959.2021.06.010]
 TANG Wen,CHEN Ai-jun.Pathogenesis of Psoriasis-related Kidney Damage[J].Journal of Medical Information,2021,34(11):36.[doi:10.3969/j.issn.1006-1959.2021.06.010]
[4]熊戌霞,蔡梦珊,吴文钦.血清鳞状细胞癌抗原在常见皮肤病中的检测价值[J].医学信息,2021,34(17):181.[doi:10.3969/j.issn.1006-1959.2021.17.050]
 XIONG Xu-xia,CAI Meng-shan,WU Wen-qin.The Value of Serum Squamous Cell Carcinoma Antigen Detection in Common Skin Diseases[J].Journal of Medical Information,2021,34(11):181.[doi:10.3969/j.issn.1006-1959.2021.17.050]
[5]谢 晗,曾同祥.IL-17在常见皮肤病中的作用[J].医学信息,2021,34(23):33.[doi:10.3969/j.issn.1006-1959.2021.23.009]
 XIE han,ZENG Tong-xiang.Role of IL-17 in Common Skin Diseases[J].Journal of Medical Information,2021,34(11):33.[doi:10.3969/j.issn.1006-1959.2021.23.009]
[6]任静静,石 瑛,智艳芳,等.基于生物信息学分析筛选银屑病的关键基因[J].医学信息,2022,35(24):1.[doi:10.3969/j.issn.1006-1959.2022.24.001]
 REN Jing-jing,SHI Ying,ZHI Yan-fang,et al.Screening of Key Genes in Psoriasis Based on Bioinformatics Analysis[J].Journal of Medical Information,2022,35(11):1.[doi:10.3969/j.issn.1006-1959.2022.24.001]
[7]黄 永,顾礼忠.NB-UVB与白芍总苷胶囊联合用于银屑病患者治疗对免疫功能及皮损PASI评分的影响[J].医学信息,2023,36(12):148.[doi:10.3969/j.issn.1006-1959.2023.12.030]
 HUANG Yong,GU Li-zhong.Effect of NB-UVB Combined with Total Glucosides of Paeony Capsule on Immune Function and PASI Score of Psoriasis Patients[J].Journal of Medical Information,2023,36(11):148.[doi:10.3969/j.issn.1006-1959.2023.12.030]

更新日期/Last Update: 1900-01-01